Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, Poland
University hospital in Białystok
Marii Skłodowskiej-Curie 24A, 15-276 Białystok
840 Beds
About Uniwersytecki Szpital Kliniczny w Bialymstoku
There are 840 beds in Uniwersytecki Szpital Kliniczny w Bialymstoku.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
6
Shire
5
Hoffmann-La Roche
3
United Therapeutics
3
BeiGene
2
CSL Behring
2
Ferring Pharmaceuticals
2
Gilead Sciences
2
Merz Pharmaceuticals GmbH
2
Actelion
1
Altavant Sciences GmbH
1
Clinical Trials at Uniwersytecki Szpital Kliniczny w Bialymstoku
During the past decade, Uniwersytecki Szpital Kliniczny w Bialymstoku conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 24 clinical trials were completed, i.e. on
average, 68.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
2008-11-01
2010-06-01
Completed
400
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
2009-01-01
2011-12-01
Terminated
821
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
2009-06-01
2010-01-01
Completed
243
Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
2009-04-01
2010-04-01
Completed
92
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
2009-09-01
2012-07-01
Completed
254
Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
2009-10-01
2010-09-01
Terminated
1,050
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
2009-12-01
2011-11-01
Terminated
15
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uniwersytecki Szpital Kliniczny w Bialymstoku" #1 sponsor was "Bayer" with 6 trials, followed by "Shire" with 5 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "United Therapeutics" with 3 trials sponsored and "BeiGene"
with 3 trials sponsored. Other sponsors include 30 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytecki Szpital Kliniczny w Bialymstoku"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were
collaborators in the rest 37 trials.
Clinical Trials Conditions at Uniwersytecki Szpital Kliniczny w Bialymstoku
According to Clinical.Site data, the most researched conditions in "Uniwersytecki Szpital Kliniczny w Bialymstoku" are
"Ulcerative Colitis" (6 trials), "Pulmonary Arterial Hypertension" (5 trials), "Crohn's Disease" (3 trials), "Diffuse Cutaneous Systemic Sclerosis" (3 trials) and "Acute Myocardial Infarction" (2 trials). Many other conditions were trialed in "Uniwersytecki Szpital Kliniczny w Bialymstoku" in a lesser frequency.
Clinical Trials Intervention Types at Uniwersytecki Szpital Kliniczny w Bialymstoku
Most popular intervention types in "Uniwersytecki Szpital Kliniczny w Bialymstoku" are "Drug" (46 trials), "Other" (8 trials), "Biological" (5 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Ontamalimab" (4 trials), "Ocrelizumab" (3 trials), "Apixaban" (2 trials) and "Enoxaparin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Uniwersytecki Szpital Kliniczny w Bialymstoku
The vast majority of trials in "Uniwersytecki Szpital Kliniczny w Bialymstoku" are
52 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Uniwersytecki Szpital Kliniczny w Bialymstoku
Currently, there are NaN active trials in "Uniwersytecki Szpital Kliniczny w Bialymstoku".
undefined are not yet recruiting,
8 are recruiting,
6 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 29 completed trials in Uniwersytecki Szpital Kliniczny w Bialymstoku,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersytecki Szpital Kliniczny w Bialymstoku, 1 "Phase 1"
clinical trials were conducted, 17 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Uniwersytecki Szpital Kliniczny w Bialymstoku
Uniwersytecki Szpital Kliniczny w Bialymstoku has several departments that took part in Clinical trials: "Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Gastroenterologii i Chorob Wewnetrznych" - 3 trials, "Uniwersytecki Szpital Kliniczny w Bialymstoku, Klinika Kardiologii z Oddzialem Intensywnego Nazdoru Kardiologicznego, M. Sklodowskiej 24a" - 2 trials